Transnational Cannabis Ltd. (TRCNF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Transnational Cannabis Ltd. (TRCNF) trades at $0.00004 with AI Score 44/100 (Grade C). Transnational Cannabis Ltd. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for TRCNF: TRCNF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TRCNF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TRCNF: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Transnational Cannabis Ltd. (TRCNF) Healthcare & Pipeline Overview
Transnational Cannabis Ltd. is a Canadian-headquartered company operating in the global cannabis sector, holding licenses for cultivation, production, supply, storage, import, export, and distribution of cannabis and its derivatives. The company focuses on both domestic and international markets, including medical cannabis products, and leverages strategic alliances to expand its operational footprint and product reach.
What Is the Investment Thesis for TRCNF?
Transnational Cannabis Ltd. operates with a comprehensive licensing framework enabling cultivation, production, and international distribution of cannabis and derivatives, positioning it to capitalize on the expanding global cannabis market. The company's strategic alliances with partners like Auxly Cannabis Group Inc. and Authentic Brands Group are crucial for enhancing product development, market access, and distribution capabilities, driving potential revenue growth in diverse segments. Its involvement in the procurement and distribution of medical cannabis products aligns with increasing global demand for therapeutic applications, representing a significant value driver. However, the company's listing on the OTC Other tier presents inherent risks, including potentially limited regulatory oversight and reduced liquidity, which could impact investor sentiment and trading efficiency. Furthermore, the cannabis industry is subject to evolving regulatory landscapes across different jurisdictions, posing ongoing compliance challenges and potential operational hurdles. Investors should monitor the company's ability to leverage its international licenses and strategic partnerships to expand market share, particularly within the medical cannabis segment, while carefully assessing the implications of its OTC market status and the dynamic regulatory environment.
Based on FMP financials and quantitative analysis
TRCNF Key Highlights
Market Capitalization: $0.00 billion, indicating a micro-cap or non-reporting status within the public markets.
- Beta: -100.16, suggesting an extremely high inverse correlation and volatility relative to the broader market.
- Dividend Policy: No dividend yield, as the company does not currently distribute dividends to shareholders.
- Operational Scope: Possesses comprehensive licenses for cultivation, production, supply, storage, import, export, and transportation of cannabis and its derivative products.
- Strategic Partnerships: Engages in key alliances with entities such as Auxly Cannabis Group Inc. and Authentic Brands Group, aiming to bolster market access and product distribution.
Who Are TRCNF's Competitors?
TRCNF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TRCNF's Key Strengths?
Comprehensive licensing for cultivation, production, and international trade of cannabis.
- Established strategic alliances with multiple key partners like Auxly Cannabis Group Inc.
- Focus on both domestic Canadian and international cannabis markets.
- Involvement in the procurement and distribution of medical cannabis products.
What Are TRCNF's Weaknesses?
Market capitalization of $0.00B, indicating a very small scale or non-reporting status.
- Extremely high negative Beta (-100.16), suggesting high volatility and inverse market correlation.
- OTC Other tier listing, implying potentially limited regulatory oversight and transparency.
- Unknown disclosure status on the OTC market, hindering investor access to information.
What Could Drive TRCNF Stock Higher?
TRCNF catalyst: Expansion of legal cannabis markets globally, potentially opening new international trade routes for Transnational Cannabis Ltd.
- Development and strengthening of existing strategic alliances to enhance product distribution and market penetration.
- Potential for new product launches or diversification within the medical cannabis derivatives segment.
- Securing additional international import/export permits or licenses in new jurisdictions.
- Increasing global demand for medical cannabis products, driving procurement and distribution activities.
What Are the Key Risks for TRCNF?
Financial-distress signal — its Altman Z-Score of -6.51 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory complexities and evolving legal frameworks in the global cannabis industry.
- High operational risk and limited liquidity associated with its OTC Other tier listing.
- Intense competition from larger, better-capitalized cannabis companies.
- Challenges in maintaining and expanding strategic alliances in a dynamic market.
- Unknown disclosure status, potentially limiting investor access to critical financial and operational information.
What Are the Growth Opportunities for TRCNF?
- International Market Expansion: The company's licenses for import and export, combined with its stated focus on international markets, represent a significant growth avenue. As more countries globally legalize cannabis for medical or recreational use, Transnational Cannabis can leverage its existing infrastructure and partnerships to enter new jurisdictions. This expansion could involve establishing new distribution channels, securing additional local licenses, or forming further strategic alliances to penetrate high-growth regions. The global legal cannabis market is projected to reach substantial valuations in the coming years, offering considerable potential for companies capable of navigating diverse regulatory landscapes and establishing robust international supply chains.
- Leveraging Strategic Alliances: Transnational Cannabis has established partnerships with key entities like Green Tree International Inc., Auxly Cannabis Group Inc., and Authentic Brands Group. These alliances can serve as powerful catalysts for growth by expanding product portfolios, enhancing distribution networks, and accessing new customer segments. For instance, collaborations could lead to co-developed products, exclusive distribution agreements, or shared market intelligence, significantly reducing market entry barriers and accelerating growth. Maximizing the value from these existing relationships and potentially forging new ones will be crucial for scaling operations and increasing market share in a competitive industry.
- Growth in Medical Cannabis Segment: The company's involvement in the procurement and distribution of medical cannabis products and derivatives positions it well within a segment experiencing robust demand. As scientific research continues to validate the therapeutic benefits of cannabis for various conditions, patient access and physician prescriptions are expected to rise globally. Focusing on product innovation, clinical efficacy, and regulatory compliance within the medical cannabis space can unlock substantial revenue streams. This segment often commands higher margins and offers a more stable demand profile compared to recreational markets, providing a strong foundation for sustainable growth.
- Product Diversification and Innovation: With licenses for production of cannabis and its derivative products, Transnational Cannabis has the opportunity to expand its product offerings beyond traditional dried flower. This includes developing and distributing a wider range of value-added products such as oils, edibles, topicals, and concentrates, which often command higher price points and cater to diverse consumer preferences. Investing in research and development to create innovative formulations and delivery methods can differentiate the company in a crowded market and capture new consumer segments, thereby increasing overall market penetration and revenue per customer.
- Vertical Integration and Supply Chain Optimization: The company's comprehensive licenses, encompassing cultivation, production, and transportation, provide a foundation for further vertical integration. By optimizing its supply chain from seed to sale, Transnational Cannabis can potentially enhance efficiency, reduce costs, and improve product quality control. This integration could involve expanding cultivation capacities, investing in advanced processing technologies, or streamlining logistics. A well-managed, vertically integrated supply chain offers greater control over product consistency and compliance, which are critical competitive advantages in the highly regulated cannabis industry, ultimately leading to improved profitability and market responsiveness.
What Threats Does TRCNF Face?
- Evolving and complex regulatory landscapes across different international jurisdictions.
- Intense competition from larger, better-capitalized cannabis operators.
- Risks associated with OTC Other tier trading, including liquidity and investor confidence.
- Potential for adverse changes in public perception or government policy regarding cannabis.
What Are TRCNF's Competitive Advantages?
- Comprehensive licensing for a wide range of cannabis activities, including cultivation, production, and international trade.
- Established strategic alliances with multiple key industry partners, enhancing market reach and capabilities.
- International operational scope with a focus on global cannabis markets.
- Specialized expertise in the procurement and distribution of medical cannabis products.
What Does TRCNF Do?
Transnational Cannabis Ltd., founded in 2006 and headquartered in Vancouver, Canada, has established itself as a multifaceted operator within the global cannabis sector. Initially known as ICC International Cannabis Corp., the company underwent a strategic rebranding in February 2020, adopting its current name to better reflect its expansive international ambitions and operational scope. Through its various subsidiaries, Transnational Cannabis holds a comprehensive suite of licenses that permit a wide array of activities crucial to the cannabis supply chain. These licenses enable the company to engage in the cultivation, production, supply, storage, import, export, and transportation of cannabis and its derivative products. This broad operational capability allows Transnational Cannabis to control multiple stages of its product lifecycle, from raw material to finished goods, ensuring quality and compliance across its value chain. A significant component of its business model involves the procurement and distribution of medical cannabis products and various cannabis derivatives, catering to the growing global demand for therapeutic applications of cannabis. The company's strategic reach extends beyond its domestic Canadian operations, with a stated focus on international markets, positioning it to capitalize on the expanding legalization and acceptance of cannabis worldwide. To bolster its market presence and operational efficiency, Transnational Cannabis has forged strategic alliances with several key partners. These include Green Tree International Inc., Auxly Cannabis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. These partnerships are instrumental in enhancing the company's capabilities in areas such as product development, distribution networks, and market access, providing a competitive edge in a rapidly evolving industry. By combining its licensed operational framework with strategic collaborations, Transnational Cannabis aims to solidify its position as a significant player in both the Canadian and international cannabis landscapes.
What Products and Services Does TRCNF Offer?
- Cultivate cannabis plants under licensed conditions.
- Produce various cannabis products and derivatives.
- Supply cannabis and its derivatives to authorized markets.
- Store cannabis products securely and compliantly.
- Import and export cannabis products across international borders.
- Transport cannabis and its derivatives within regulatory frameworks.
- Procure medical cannabis products from various sources.
- Distribute medical cannabis products and derivatives to designated channels.
How Does TRCNF Make Money?
- Generates revenue from the sale of cultivated and produced cannabis products.
- Earns income through the distribution of medical cannabis and its derivatives.
- Benefits from international trade activities, including import and export of cannabis products.
- Creates value through strategic alliances that enhance market access and product development capabilities.
What Industry Does TRCNF Operate In?
Transnational Cannabis Ltd. operates within the dynamic and rapidly evolving global cannabis sector, specifically categorized under Drug Manufacturers - Specialty & Generic. This industry is characterized by significant regulatory complexities and varying legal frameworks across jurisdictions, which present both challenges and substantial growth opportunities. A key market trend is the ongoing expansion of legal cannabis markets worldwide, driven by increasing medical acceptance and recreational legalization initiatives. This trend creates a fertile ground for companies with comprehensive licensing and international distribution capabilities. The competitive landscape is fragmented, featuring numerous players ranging from large multi-state/multi-country operators to smaller, specialized cultivators and distributors. Transnational Cannabis positions itself through its broad licensing for cultivation, production, and international trade, coupled with a focus on medical cannabis products. Its strategic alliances are critical in navigating this competitive environment, enabling broader market reach and diversified product offerings within a sector projected for substantial growth as regulatory barriers continue to ease in various regions.
Who Are TRCNF's Key Customers?
- Licensed distributors and retailers in domestic and international cannabis markets.
- Medical patients accessing products through authorized medical cannabis channels.
- Strategic partners for collaborative product development and distribution initiatives.
- Wholesale buyers of cannabis and various derivative products.
How Transnational Cannabis Ltd. Is Valued
Relative to its peer group, TRCNF's quantitative score of 44/100 is below the peer average of 62/100.
Company Profile
Transnational Cannabis Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO David Shpilt. TRCNF has traded publicly since 2018.
Key Financial Metrics
Return on assets is -86.5%, showing how much profit it generates from its asset base. A current ratio of 1.40 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
Transnational Cannabis Ltd.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.51 places it in the distress zone, a signal of elevated financial risk.
TRCNF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that leadership believes in a turnaround or growth phase.
- Community sentiment has shifted positively as discussions around cannabis legalization gain momentum, enhancing optimism for companies in the sector.
- Transnational Cannabis has been actively expanding its product lines, which may attract a broader customer base and increase market share.
- Social media sentiment reflects increasing interest in cannabis stocks, with many retail investors expressing enthusiasm about potential growth in the industry.
Bear Case
- Despite positive sentiment, regulatory uncertainties surrounding cannabis remain a significant concern, potentially impacting future operations and profitability.
- Recent discussions in the community also highlight skepticism about the company's ability to compete with larger, more established players in the cannabis market.
- There is a noticeable lack of recent product innovation, which could hinder the company's ability to attract new customers and retain existing ones.
- Market perception remains cautious, with some investors worried about the sustainability of the recent bullish trends in the cannabis sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
TRCNF Latest News
No recent news available for TRCNF.
TRCNF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TRCNF.
Price Targets
Wall Street price target analysis for TRCNF.
TRCNF MoonshotScore
What does this score mean?
The MoonshotScore rates TRCNF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: David Shpilt
Chief Executive Officer
Unknown. Specific details regarding David Shpilt's career history, educational background, and previous roles prior to his tenure at Transnational Cannabis Ltd. are not provided in the source data.
Track Record: Unknown. Key achievements, strategic decisions, or company milestones directly attributable to David Shpilt's leadership at Transnational Cannabis Ltd. are not detailed in the provided information.
TRCNF OTC Market Information
Transnational Cannabis Ltd. trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial reporting, corporate governance, and minimum share prices, companies on the OTC Other tier have minimal to no reporting requirements with the SEC. This tier is typically for companies that do not meet the standards for OTCQX or OTCQB, or choose not to report. It often involves companies with limited public information, making due diligence more challenging for investors.
- OTC Tier: OTC Other
- Limited regulatory oversight and financial transparency due to minimal reporting requirements.
- Significantly lower liquidity, leading to wider bid-ask spreads and difficulty in trading shares.
- Increased susceptibility to market manipulation and fraudulent activities.
- Difficulty in obtaining reliable and timely financial information for informed decision-making.
- Higher volatility and potential for significant price fluctuations due to low trading volume.
- Verify the company's current operational status and active licenses in all jurisdictions.
- Scrutinize any available financial statements for revenue, profitability, and cash flow trends.
- Research the background and track record of management and board members.
- Investigate any news or regulatory filings from Canadian authorities (as HQ is Canada).
- Assess the legitimacy and activity of its stated strategic alliances and partnerships.
- Evaluate the competitive landscape and the company's specific niche within the cannabis market.
- Understand the specific regulatory environment in all jurisdictions where it operates.
- Headquartered in Vancouver, Canada, a country with federally legal cannabis.
- Explicitly states holding necessary licenses for comprehensive cannabis activities.
- Has established strategic alliances with named partners (e.g., Auxly Cannabis Group Inc.).
- Founded in 2006, indicating a long operational history, albeit with a name change.
- Operates in a regulated industry (healthcare/drug manufacturers).
Transnational Cannabis Ltd. Healthcare Stock: Key Questions Answered
What does the AI Score mean for TRCNF?
TRCNF holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Transnational Cannabis Ltd. is a Canadian-headquartered company operating in the global cannabis sector, holding licenses for cultivation, production, supply, storage, import, export, …
What does Transnational Cannabis Ltd. do?
Transnational Cannabis Ltd. operates across the entire cannabis value chain, leveraging its comprehensive licenses to cultivate, produce, supply, store, import, export, and transport cannabis and its derivative products. Headquartered in Vancouver, Canada, the company focuses on both domestic and international markets, with a significant emphasis on the procurement and distribution of medical cannabis products.
What are the main risks for TRCNF?
Investing in Transnational Cannabis Ltd. involves several key risks, primarily stemming from its listing on the OTC Other tier, which implies significantly lower liquidity and potentially limited regulatory oversight compared to major exchanges. The company's unknown disclosure status further exacerbates transparency concerns, making it challenging for investors to access comprehensive financial and operational data.
How does Transnational Cannabis Ltd. navigate regulatory approval processes?
Transnational Cannabis Ltd. navigates regulatory approval processes by holding a comprehensive suite of necessary licenses for its diverse operations, including cultivation, production, import, export, and distribution of cannabis and its derivatives. Given its headquarters in Canada, the company operates within a federally regulated cannabis framework, which provides a structured environment for its domestic activities.
What are the key factors to evaluate for TRCNF?
Transnational Cannabis Ltd. (TRCNF) holds an AI score of 44/100 (low). operates with a comprehensive licensing framework enabling cultivation, production, and international distribution of cannabis and derivatives, positioning it to capitalize on the expanding global cannabis market. Not financial advice.
How frequently does TRCNF data refresh on this page?
TRCNF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven TRCNF's recent stock price performance?
Transnational Cannabis Ltd. (TRCNF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive licensing for cultivation, production, and international trade of cannabis. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TRCNF overvalued or undervalued right now?
Transnational Cannabis Ltd. (TRCNF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research TRCNF before investing?
Before investing in Transnational Cannabis Ltd. (TRCNF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Specific details regarding CEO background and track record were not provided in the source data and are marked as 'Unknown'.
- Competitor information (FMP PEER TICKERS) was not provided in the source data.
- Market sizes and specific timelines for growth opportunities are general inferences based on industry trends, as precise figures were not supplied.
- The company's disclosure status on the OTC market is explicitly stated as 'Unknown'.